Top Banner
Dr. Sanjeev Mehta Dr. Sanjeev Mehta MD MD Metabolic and Renal Stone Analysis : Current prospective Uro Lab. 1
29

Stone disease evaluation in Pathology laboratory: Current prospective.

Jul 08, 2015

Download

Health & Medicine

Sanjeev Mehta

Urinary Stone disease is painful and destructive disease. It has a bad habit of recurrence. Patients need to be thoroughly investigated and now due to advancements in laboratory, it is possible to know exact cause of stone formation in about 90% cases. This helps in focal prophylactic treatment to effectively stop recurrence.
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Stone disease evaluation in Pathology laboratory: Current prospective.

Dr. Sanjeev Mehta Dr. Sanjeev Mehta MDMD

Metabolic and Renal Stone Analysis : Current prospective

Uro Lab. 1

Page 2: Stone disease evaluation in Pathology laboratory: Current prospective.

Stone disease evaluation in Laboratory

• Series of tests to identify underlying causes.

1.Identify treatable metabolic abnormality

2.Identify underlying medical disease that predisposes to stone formation.

3.Outline a treatment plan ; focal

Uro Lab. 2

Page 3: Stone disease evaluation in Pathology laboratory: Current prospective.

Why Do Kidney Stones Form?

• Reasons: Gnetic/dietary/Environmental• Urine is supersaturated• 2009: Supersaturation can be “fix” • Therefore, our job is to figure out what is

causing the urinary Supersaturation and

How best to fix it!

Uro Lab. 3

Page 4: Stone disease evaluation in Pathology laboratory: Current prospective.

Stone Formation : Supersaturation

• k

Uro Lab. 4

Page 5: Stone disease evaluation in Pathology laboratory: Current prospective.

Actually up to 65 different chemical compounds are found in urinary calculi.

Uro Lab. 5

Page 6: Stone disease evaluation in Pathology laboratory: Current prospective.

Metabolic evaluation

• Blood and Urinary Tests ; routine• Stone Analysis• 24 hrs Urinary Metabolic Profile with

SUPERSATURTION.

New advances in Stone analysis, Blood and Urinary Chemical analysis can find out 90-95% cause.*

* Preminger G.M., “Guidelines for medical management of urolithiasis”, bussin. meet us kid and urol dis,2005

Uro Lab. 6

Page 7: Stone disease evaluation in Pathology laboratory: Current prospective.

Evaluation : First time stone with low risk• Blood screen;

Low K and HCO3, High Chloride - RTA

High Uric acid - gouty diathesis

High Calcium - Pri. Hyperparathyroidism

Low Phosphorus – Renal phosphate leak.

• Stone analysis ; all cases

Uro Lab. 7

Page 8: Stone disease evaluation in Pathology laboratory: Current prospective.

Evaluation: First time stone

• Urine

Urinalysis : Routine

pH > 7.5 - infection lithiasis

pH < 5.5 - Uric acid lithiasis

Sediments for crystalluria

Urine culture :

Urea-splitting organisms – infection lithiasis.

Screening / quantitative CystineUro Lab. 8

Page 9: Stone disease evaluation in Pathology laboratory: Current prospective.

24 hrs Urine metabolic profile ; Extensive

Uro Lab. 9

Page 10: Stone disease evaluation in Pathology laboratory: Current prospective.

24 hrs extensive Metabolic evaluation: indications

• Stone recurrence• Motivated patients wants to investigate.• Select one-time formers:

- Solitary Kidney

- Renal insufficiency.- Residual stone burden.• All children

Uro Lab. 10

Page 11: Stone disease evaluation in Pathology laboratory: Current prospective.

Extensive Metabolic Evaluation

24 hrs Urine collections.

Stone risk factors :

Volume

Calcium , Calcium to creatinine index.

Oxalate . ?Primary hyperoxaluria

Citrate

Uric acid.

Uro Lab. 11

Page 12: Stone disease evaluation in Pathology laboratory: Current prospective.

Extensive Metabolic Evaluation

• Dietary risk factors:

Sodium,

Potassium

Magnesium

Urinary analytes : phosporus, sulfate, Urea

Marker for accuracy : Creatinine.

Repeat 24 hrs Urine collection 4-6 weeks post intervantion.

Uro Lab. 12

Page 13: Stone disease evaluation in Pathology laboratory: Current prospective.

24 hrs Urine metabolic profile graph

Uro Lab. 13

Page 14: Stone disease evaluation in Pathology laboratory: Current prospective.

Follow-up in same patient

Uro Lab. 14

Page 15: Stone disease evaluation in Pathology laboratory: Current prospective.

Stone analysis

Uro Lab. 15

Page 16: Stone disease evaluation in Pathology laboratory: Current prospective.

• Essential step in the examination and initial treatment of Urolithiasis.

• Composition yields fundamental information of pathogenesis of disease like ;- Metabolic abnormality.- Presence of infection.- Possible artifacts.- Drug metabolism.

Renal Calculus Analysis

Uro Lab. 16

Page 17: Stone disease evaluation in Pathology laboratory: Current prospective.

Integrated analysis: Techniques

• Optical Crystallogrphy• Chemical Microscopy.• Polarizing Microscopy.• Infrared spectroscopy.• X-ray diffraction.• Electron Microscopy• Fluorescence and chromatography.• Final , semi quantitative, modified estimate from

above results.

* herringlab.comUro Lab. 17

Page 18: Stone disease evaluation in Pathology laboratory: Current prospective.

Significance of Stone analysis

• Exact composition gives important clue as to how Stone formed.

• Information may not available from any other type of work-up.

• Identify factors leading to clinical events.• Identify Risk factors.

Uro Lab. 18

Page 19: Stone disease evaluation in Pathology laboratory: Current prospective.

Significance of Stone analysis

Three categories :

1.Composition and hardness of Renal Stones.

2.Composition and its predictive value.

3.Composition and related metabolic abnormalities.

Uro Lab. 19

Page 20: Stone disease evaluation in Pathology laboratory: Current prospective.

Hardness Factor of Stone

Calcium Oxalate Dihydrate 1.0

Calcium Oxalate Monohydrate 1.3

Hydroxy-peptite 1.1

Brushite 2.2

Uric Acid/ Urate 1.0

Cystine 2.4

Carbonate Apatite 1.3

Struvite 1.0

Mixed Stone 1.0* Ringden I, Scand J Urol Nephrol.2007;41(4):316-23

Uro Lab. 20

Page 21: Stone disease evaluation in Pathology laboratory: Current prospective.

Clinical Significance: Hardness pattern in Stone.

• Useful in describing consistency in individual.• Formulation of treatment strategies.

- Number of re-treatments.

- Number of Shock waves. • Energy index (KV x number of shock waves).

• PMID:17763224( PubMed-indexed for MEDLINE)

Uro Lab. 21

Page 22: Stone disease evaluation in Pathology laboratory: Current prospective.

Calcium stone….

• Pure Calcium oxalate: More Acid urine, Low urine volume, high oxalate excretion.

• Mixed Stone formers ;

High Calcium, pH and Stone formation rate.

High Calcium excretion.

* Schroeppel j Smith et all ; J Am Soc Nephrol 1997;8:568AUro Lab. 22

Page 23: Stone disease evaluation in Pathology laboratory: Current prospective.

Calcium…..

• Calcium Oxalate Monohydrate :

Hypomagnesuria, acid urine, low volume

More hard then dihydrate.• Calcium Oxalate Dihydrate :

- hypercalciuria. High Urine pH and hypocitraturia.

Uro Lab. 23

Page 24: Stone disease evaluation in Pathology laboratory: Current prospective.

Calcium Stone with …

Carbonate apatite : may indicate Renal Tubular Acidosis (RTA).

- Increases with amount of apatite.

( 5 – 39%).

Brushite Stones : Consider Renal tubular Acidosis (RTA).

Uro Lab. 24

Page 25: Stone disease evaluation in Pathology laboratory: Current prospective.

Struvite Stones• Mixed Stone, infection. Mostly Proteus

Ammonium Urate • Elders : associated with infection.• Children : May also form as result of

hyperuricosuria, but NO urinary tract infection.

• Rare in pure form (0.03%)Uro Lab. 25

Page 26: Stone disease evaluation in Pathology laboratory: Current prospective.

Uric Acid

• Hyperuricemia, hyperuricosuria.• Low Urine Ph. < 6.2• Causes:

- Gout.

- Myeloproliferative processes associated with pathological increased purine metabolism.

- Chemotherapy and Radiotherapy.Uro Lab. 26

Page 27: Stone disease evaluation in Pathology laboratory: Current prospective.

Rare

Cystine : • Cysteinuria. Acidic• Autosomal recessive disorder.

Xenthene: • Xanthinuria.• Absence of Xanthinooxidase.• Genetic autosomal hereditary recessive

enzyme disorder.

Uro Lab. 27

Page 28: Stone disease evaluation in Pathology laboratory: Current prospective.

Conclusion.

• Combined with Optical Crystallography, appropriate Blood & 24 Urine metabolic work-up with super-saturation, it can find out the cause of stone formation in nearly all cases

• Supersaturation Index is GOLD Standard to know exactly patho-physiological basis of Stone formation to guide proper treatment.

Uro Lab. 28

Page 29: Stone disease evaluation in Pathology laboratory: Current prospective.

Thank You !Uro Lab. 29